The molecular mechanisms involved in papillary renal cell carcinoma (pRCC) development and drug resistance are diverse. In this Review, the authors summarize the current understanding of the mechanisms of resistance to currently used therapies in pRCC and make recommendations for future preclinical and clinical studies.
- Anna Brodziak
- Paweł Sobczuk
- Anna M. Czarnecka